285
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Motor neuron disease: Classification and nomenclature

Pages 105-112 | Published online: 10 Jul 2009

  • Aran FA. Recherches sur une maladie non encore décrite du système musculaire (atrophie musculaire progressive). Arch Gen Med 1850; 24: 5-35, 172-214.
  • Duchenne de Boulogne GBA. Recherches faites à l'ordre des galvanisime sur l'état de la contractilité et de la sensibilité électromusculaires dans les paralysies des membres supérieurs. CR Acad Sci (Paris) 1849; 29: 667.
  • Cruveilhier J. Sur la paralysie musculaire, progressive, atrophique. Bull Acad Med (Paris) 1852-1853; 18: 490-546.
  • Luys JB. Atrophie musculaire progressive. Lésions histologiques de la substance grise de la moelle épinière. Gaz Med (Paris) 1860; 15: 505.
  • Charcot JM, Joffroy A. Deux cas d'atrophie musculaire progressive avec lésions de la substance grise et des faisceaux antéro-latéraux de la moelle épinière. Arch Physiol Neurol Path 1869; 2:744.
  • Duchenne de Boulogne GBA. Paralysie musculaire progressive de la langue, du voile du palais et des lèvres: affection non encore décrite comme espèce morbide distincte. Arch Gén Méd 1860; 16: 283-431.
  • Spiller WG. Primaiy degeneration of the pyramidal tracts: a study of eight cases with necropsy. Univ Penn Med Bull 1904; 17: 390-395.
  • Brain WR. In: Diseases of the nervous system (6th edn) Oxford: Oxford University Press, 1962: 531.
  • Rowland LP. Diverse forms of motor neuron disease. In: Rowland LP, ed. Human motor neuron diseases. New York: Raven Press, 1982: 1-13.
  • WFN-ALS web-site, 1998: http://www.wfnals.org/Airlie criteria/ and J Neurol Sci (in press).
  • Lisen A, Calne D. Amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease: phylogenetic disorders of the human neocortex sharing many characteristics. Can J Neurol Sci 1992; 19: 117-123.
  • Iwanaga K, Hayashi S, Okaye M et al. Neuropathology of sporadic amyotrophic lateral sclerosis of long duration.) Neurol Sci 1997; 146: 139-143.
  • Sasaki S, Tsutsumi Y, Yamani K, Sakuma H, Maruyama S. Sporadic amyotrophic lateral sclerosis with extensive neurological involvement. Acta Neuropathol 1992; 84: 211-215.
  • Przedborski S, Shawan V, Donaldson DM et al. Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc Superoxide dismutase mutations. Neurology 1996; 47: 1546-1551.
  • Takahashi H, Snow BJ, Bhatt MH, Peppard R, Eisen A, Calne DB. Evidence of a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Eancet 1993; 324: 1016-1018.
  • Borasio GD, Linke R, Schwartz J et al. Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [1-131] IPT single photon emission computed tomography. J Neurol Neurosurg Psychiatiy 1998; 65: 263-265.
  • Kostic V, Gumey ME, Deng HX, Siddique T, Epstein CJ, Przedborski S. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann Neurol 1997; 41: 497-504.
  • Orrell RW, King AW, Hilton DA et al. Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatiy 1995; 59: 266-267.
  • Kew J, Leigh HN. Dementia with motor neuron disease. In: Rossor MN, ed. Bailliere's Clinical Neurology: Unusual dementias. 1992: 611-626.
  • Neary D, Snowden JS, Mann DMA et al. Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry 1990; 53: 23-32.
  • Wightman G, Anderson VER, Martin J et al. Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neuroscience Eett 1992; 139: 269-274.
  • Bouche P, Moulonguet A, Younes-Chennoufi AB et al. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 1995; 59: 38-44.
  • Kaji R, Shibasaki H, Kimura J. Multifocal motor neuropathy: cranial nerve involvement and immunoglobulin therapy. Neurology 1992; 42: 506-509.
  • Van den Berg EH, Franssen H, and Wokke JHJ. The longterm effect of intravenous immunoglobulin treatment in multifocal motor neuropathy. Brain 1998; 121: 421-428.
  • Adams D, Kuntzer T, Steck AJ, Lobrinus A, Janzer RC, Regli F. Motor conduction block and high titres of anti-GMl ganglioside antibodies: pathological evidence of a motor neuropathy in a patient with lower motor neuron syndrome. J Neurol Neurosurg Psychiatiy 1993; 56: 982-987.
  • Oh SJ, Claussen GC, Odabasi Z, Palmer CP. Multifocal demyelinating motor neuropathy: pathologic evidence of 'inflammatory demyelinating polyradiculoneuropathy'. Neurology 1995; 45: 1828-1832.
  • Veugelers B, Theys P, Lammens M, Van Hees J, Robberecht W. Pathological findings in a patient with amyotrophic lateral sclerosis and multifocal motor neuropathy with conduction block. J Neurol Sci 1996; 136: 64-70.
  • Rowland LP. Controversies about amyotrophic lateral sclerosis. Neurologia 1996; 11 (Suppl 5): 72-74.
  • Verma A, Berger JR, Snodgrass S, Petito C. Motor neuron disease: a paraneoplastic process associated with anti-Hu antibody and small cell lung carcinoma. Ann Neurol 1996; 40: 112-116.
  • Forsyth PA, Dalmau J, Graus F et al. Motor neuron syndromes in cancer patients. Ann Neurol 1997; 41: 722-730.
  • Khwaja S, Sripathi N, Ahmad BK, Eennon VA. Paraneoplastic motor neuron disease with typel Purkinje cell antibodies. Muscle Nerve 1998; 21: 943-945.
  • Rowland EP. Paraneoplastic primary lateral sclerosis and amyotrophic lateral sclerosis. Ann Neurol 1997; 41: 703-705.
  • Brain WR, Norris FH Jr, eds. The remote effects of cancer on the nervous system. New York: Grune & Stratton, 1965.
  • Desai J, Swash M. IgM paraproteinaemia in a patient with primary lateral sclerosis. Neuromuscular Disord 1999; 9: 38-40.
  • Gordon PH, Rowland LP, Younger DS et al. Lymphoproliferative disorders and motor neuron disease; an update. Neurology 1997; 48: 1671-1678.
  • Younger DS, Rowland LP, Latov N et al. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology 1990; 40: 595-599.
  • Andersen PM, Nilsson P, Kernen M-L et al. Phenotypic heterogeneity in motor neuron disease patients with Cu/Znsuperoxide dismutase mutations in Scandinavia. Brain 1997; 120: 1723-1737.
  • Appelbaum JS, Roos RP, Salazar-Grueso EF et al. lntrafamilial heterogeneity in hereditary motor neuron disease. Neurology 1992; 42: 1488-1492.
  • Williams DB, Floate DA, Leicester J. Familial motor neuron disease: differing penetrance in large pedigrees. J Neurol Sci 1988; 86: 215-230.
  • Radunovic A, Leigh PN on behalf of the European Familial ALS Group. Cu/Zn Superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. J Neurol Neurosurg Psychiatry 1996; 61: 565-572.
  • Cudkowicz ME, McKenna-Yasek D, Chen C, Hedley-Whyte ET, Brown RH. Limited corticospinal tract involvement in ALS subjects with the A4V mutation in the Cu/Zn Superoxide dismutase gene. Ann Neurol 1998; 43: 703-710.
  • Rowland LP. What's in a name? ALS, motor neuron disease, and alleleic heterogeneity. Ann Neurol 1998; 43: 691-694.
  • Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset; a sex-linked recessive trait. Neurology 1968; 18: 671-680.
  • LaSpada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991; 352: 77-79.
  • Ferlini A, Patrosso MC, Guidetti D et al. Androgen receptor gene (CAG) in repeat analysis on the differential diagnosis between Kennedy disease and other motor neuron disorders. Am J Med Genet 1995; 55: 105-111.
  • Shaw PJ, Thagesen H, Tomkins J et al. Kennedy's disease: unusual molecular pathologic and clinical features. Neurology 1998; 51: 252-255.
  • Parboosingh JS, Figlewicz DA, Krizus A et al. Spinobulbar muscular atrophy can mimic ALS; the importance of genetic testing in male patients with atypical ALS. Neurology 1997; 49: 568-572.
  • Ben Hamida M, Hentati F, Ben Hamida C. Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Brain 1990; 113: 347-363.
  • Hentati A, Bejaoui K, Pericak-Vance MA et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q 33-35. Nat Genet 1994; 7: 425-428.
  • Hentati A, Ouahchi K, Pericak-Vance MA et al. Linkage of a common locus for recessive amyotrophic lateral sclerosis. Am J Hum Genet 1997; Suppl 61: A279.
  • Chance PF, Rabin BA, Ryan SG et al. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am J Hum Genet 1998; 62: 633-640.
  • Meenakshisundaram E, Jagannathan K, Ramamurthi B. Clinical pattern of motor neuron disease seen in younger age groups in Madras. Neurol India 1970; 18: 109.
  • Gourie-Devi M, Suresh TG. Madras pattern of motor neuron disease in South India. J Neurol Neurosurg Psychiatiy 1988; 51: 773-777.
  • Wadia PN, Bhatt MH, Misra VP. Clinical neurophysiological examination of deafness associated with juvenile motor neurone disease. J Neurol Sci 1987; 78: 29-33.
  • Jagannathan K, Kumaresan G. Madras pattern of motor neuron disease. In: Gourie-Devi M, ed. Motor neurone disease. New Delhi: Oxford and IBH, 1987: 191-194.
  • Hirayama K, Tomonaga M, Kitano K, Yamada T, Kojima S, Arai K. Focal cervical poliopathy causing juvenile muscular atrophy of distal upper extremity: a pathological study. ) Neurol Neurosurg Psychiatiy 1987; 50: 285-290.
  • Singh N, Sachdev KK, and Susheela AK. Juvenile muscular atrophy localized to arms. Arch Neurol 1980; 37: 297-299.
  • Gourie-Devi M, Suresh TG, Shankar SK. Monomelic amyotrophy. Arch Neurol 1984; 41: 388-394.
  • Arnold A, Edgren DC, Palladino VS. ALS: Fifty cases observed on Guam. ) Nerv Ment Dis 1953; 117: 135-139.
  • Koerner DB. Amyotrophic lateral sclerosis on Guam: a clinical study and review of the literature. Ann Intern Med 1952; 37: 1204-1220.
  • Mulder DW, Kurland LT, Iriarte LLG. Neurologic diseases on the island of Guam. US Armed Forces Med J 1954; 5: 1724-1739.
  • Rogers-Johnson P, Garruto R, Yanagihara R et al. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 30 year evaluation of clinical and neuropathological trends. Neurology 1986; 36: 7-13.
  • Hirano A, Malamud N, Kurland LT. Parkinsonism-dementia complex, an endemic disease on the island of Guam: II. Pathological features. Brain 1961; 84: 662-679.
  • McGeer PL, Schwab C, McCeer EG, Haddock RL, Steele JC. Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam. Neurology 1997; 49: 400-409.
  • Shiraki H, Yase Y. Amyotrophic lateral sclerosis in Japan. In. Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology, vol 16. New York: Elsevier, 1975: 353-418.
  • Gajdusek DC, Salazar A. Amyotrophic lateral sclerosis and parkinsonian syndromes among the Auyu and Jakai people of West New Guinea. Neurology 1982; 32: 107-126.
  • Spillantini MG, Bird TD, Ghetti B. Frontotemporal dementia linked to chromosome 17: a new group of tauopathies. Brain Pathol 1998; 8: 387-402.
  • Rothstein JD. Excitotoxicity hypothesis. Neurology 1996; 47(Suppl2):S19-S26.
  • Rothstein JD, Van Kammen M, Levey AI et al. Selective loss of glial glutamate transporter GLT-l in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73-84.
  • Lin G, Bristol LA, Jin L et al. Aberrant RNA processing in a neurodegenerative disease: a common cause for loss of glutamate transporter EAAT2 protein in sporadic amyotrophic lateral sclerosis. Neuron 1998; 20: 589-602.
  • Li X, Francke U. Assignment of the gene SLC1A2 coding for the human glutamate transporter EAAT2 to human chromosome 11 bands p12-p13. Cytogenet Cell Genet 1995; 71: 212-213.
  • Aoki M, Lin CG, Rothstein JD et al. Mutations in the glutamate transporter EEAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann Neurol 1998; 43: 645-653.
  • Beckman JS, Carson M, Smith CD et al. ALS, SOD, and peroxynitrite. Nature 1993; 364: 584.
  • Carpenter S. Proximal axonal enlargement in motor neuron diseases. Neurology 1968; 18: 841-851.
  • Sobue G, Hashizume Y, Yasuda T et al. Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells. Acta Neuropathol 1990; 79: 400-408.
  • Rouleau GA, Clark AW, Rooke K et al. SODl mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 128-131.
  • Figlewicz DA, Krizus A, Martinoli MG et al. Variants of the heavy neurofilament sub-unit gene are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 1757-1761.
  • Rooke K, Figlewicz DA, Han F, Rouleau GA. Analysis of the KSP repeat of the neurofilament heavy sub-unit in familial amyotrophic lateral sclerosis. Neurology 1996; 46: 789-790.
  • Vecchio JD, Bruijn Ll, Xu Z, Brown RH, Cleveland DW. Sequence variants in human neurofilament proteins: Absence of linkage to familial amyotrophic lateral sclerosis. Ann Neurol 1996; 40: 603-610.
  • Hirano A. The cytopathology of amyotrophic lateral sclerosis. Adv Neurol 1991; 56: 91-101.
  • Jackson M, Lennox M, Lowe J. Motor neurone disease inclusion body dementia. Neurodegen 1996; 4: 339-350
  • Bruijn Ll, Becher MW, Lee MK et al. ALS-linked SODl mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SODl containing inclusions. Neuron 1997; 18: 327-328.
  • Gumey ME, Pu H, Chiu AY et al. Motor neuron degeneration in mice that express a human Cu/Zn Superoxide dismutase mutation. Science 1994; 264: 1772-1775.
  • Zhang B, Tu PH, Abtahian F et al. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SODl with a G93A mutation. J Cell Biol 1997; 139: 1307-1315.
  • Breuer AC, Lynn MP, Atkinson MB et al. Fast axonal transport in amyotrophic lateral sclerosis: An intra-axonal organelle traffic analysis. Neurology 1987; 37: 738-748.
  • Xu Z, Cork LC, Griffin JW et al. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 1993; 73: 23-33.
  • Cote F, Collard JF, Julien JP. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 1993; 73: 35-46.
  • Lee MK, Marszalek JR, Cleveland DW. A mutant neurofilament subunit causes massive selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 1994; 13: 975-988.
  • Rosenberg RN. Autosomal dominant cerebellar phenotypes: the genotype will settle the issue. Neurology 1990; 40: 1329-1331.
  • Rosenberg RN. Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology 1995; 45: 1-5.
  • Ozawa E, Noguchi S, Mizuno Y, Hagiwara Y, Yoshida M. From dystroph inopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle Nerve 1998; 21: 421-438.
  • Mendell JR. Charcot-Marie-Tooth neuropathies and related disorders. Semin Neurol 1998; 18: 41-47.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.